Merus N.V (NASDAQ: MRUS) on Tuesday, soared 5.15% from the previous trading day, before settling in for the closing price of $40.20. Within the past 52 weeks, MRUS’s price has moved between $37.77 and $61.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 12.64%. The company achieved an average annual earnings per share of -26.42%. With a float of $56.92 million, this company’s outstanding shares have now reached $68.43 million.
Let’s determine the extent of company efficiency that accounts for 229 employees. In terms of profitability, gross margin is -4.25%, operating margin of -642.76%, and the pretax margin is -659.93%.
Merus N.V (MRUS) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Merus N.V is 16.86%, while institutional ownership is 95.78%. The most recent insider transaction that took place on Aug 21 ’24, was worth 135,000. In this transaction VP Controller, PAO of this company sold 2,500 shares at a rate of $54.00, taking the stock ownership to the 7,002 shares. Before that another transaction happened on Aug 20 ’24, when Company’s VP Controller, PAO sold 2,500 for $54.00, making the entire transaction worth $135,000. This insider now owns 7,002 shares in total.
Merus N.V (MRUS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -26.42% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.37% during the next five years compared to -18.50% drop over the previous five years of trading.
Merus N.V (NASDAQ: MRUS) Trading Performance Indicators
Merus N.V (MRUS) is currently performing well based on its current performance indicators. A quick ratio of 8.32 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 80.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.91, a number that is poised to hit -0.92 in the next quarter and is forecasted to reach -3.90 in one year’s time.
Technical Analysis of Merus N.V (MRUS)
Looking closely at Merus N.V (NASDAQ: MRUS), its last 5-days average volume was 0.44 million, which is a drop from its year-to-date volume of 0.58 million. As of the previous 9 days, the stock’s Stochastic %D was 35.81%. Additionally, its Average True Range was 1.68.
During the past 100 days, Merus N.V’s (MRUS) raw stochastic average was set at 25.54%, which indicates a significant decrease from 72.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 32.90% in the past 14 days, which was lower than the 39.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $41.76, while its 200-day Moving Average is $48.97. However, in the short run, Merus N.V’s stock first resistance to watch stands at $43.40. Second resistance stands at $44.53. The third major resistance level sits at $45.96. If the price goes on to break the first support level at $40.84, it is likely to go to the next support level at $39.41. Should the price break the second support level, the third support level stands at $38.28.
Merus N.V (NASDAQ: MRUS) Key Stats
Market capitalization of the company is 2.89 billion based on 68,464K outstanding shares. Right now, sales total 43,950 K and income totals -154,940 K. The company made 11,770 K in profit during its latest quarter, and -99,910 K in sales during its previous quarter.
